These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6302123

  • 1. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T, Tozawa F, Mouri T, Sasaki A, Shibasaki T, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [Abstract] [Full Text] [Related]

  • 2. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
    Suda T, Tomori N, Tozawa F, Demura H, Shizume K.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
    [Abstract] [Full Text] [Related]

  • 3. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW, Verleun T, Oosterom R, de Jong F, Hackeng WH.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [Abstract] [Full Text] [Related]

  • 4. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Nakashima H, Hirata Y, Uchihashi M, Tomita M, Fujita T.
    Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
    [Abstract] [Full Text] [Related]

  • 5. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T, Nakahara M, Shizume K, Kiyosawa Y, Suda T, Demura H, Kuwayama A, Kageyama N, Benoit R, Ling N.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [Abstract] [Full Text] [Related]

  • 6. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Nakagami Y, Suda T, Yajima F, Ushiyama T, Tomori N, Sumitomo T, Demura H, Shizume K.
    Brain Res; 1986 Oct 29; 386(1-2):232-6. PubMed ID: 3022879
    [Abstract] [Full Text] [Related]

  • 7. Anterior pituitary hormones in plasma and pituitaries from patients with Cushing's disease.
    Suda T, Demura H, Demura R, Jibiki K, Tozawa F, Shizume K.
    J Clin Endocrinol Metab; 1980 Nov 29; 51(5):1048-53. PubMed ID: 6252228
    [Abstract] [Full Text] [Related]

  • 8. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
    Oosterom R, Verleun T, Uitterlinden P, Hackeng WH, Burbach JP, Wiegant VM, Lamberts SW.
    Acta Endocrinol (Copenh); 1984 May 29; 106(1):21-9. PubMed ID: 6328819
    [Abstract] [Full Text] [Related]

  • 9. In vitro secretion of ACTH, beta-endorphin and beta-lipotropin in Cushing's disease and Nelson's syndrome.
    Lüdecke DK, Westphal M, Schabet M, Höllt V.
    Horm Res; 1980 May 29; 13(4-5):259-79. PubMed ID: 6268513
    [Abstract] [Full Text] [Related]

  • 10. Discordances in the temporal pattern of the ACTH/beta-endorphin releasing effects of synthetic CRFs and partially purified bovine CRF in a superfusion system.
    Yasuda Y, Yasuda N.
    Horm Metab Res; 1986 May 29; 18(5):313-7. PubMed ID: 3013743
    [Abstract] [Full Text] [Related]

  • 11. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B, Deuss U, Kaulen D, Leonhardt U, Kallabis D, Hamel E, Winkelmann W.
    J Clin Endocrinol Metab; 1986 Dec 29; 63(6):1427-31. PubMed ID: 3023423
    [Abstract] [Full Text] [Related]

  • 12. Corticotropin releasing factor (CRF): diagnostic implications.
    Müller OA, Stalla GK, Hartwimmer J, Schopohl J, von Werder K.
    Acta Neurochir (Wien); 1985 Dec 29; 75(1-4):49-59. PubMed ID: 2986422
    [Abstract] [Full Text] [Related]

  • 13. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR, Nowakowski KJ, Jackson IM.
    J Endocrinol Invest; 1989 Mar 29; 12(3):197-200. PubMed ID: 2542391
    [Abstract] [Full Text] [Related]

  • 14. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.
    Westphal M, Jaquet P, Wilson CB.
    Acta Neuropathol; 1986 Mar 29; 71(1-2):111-8. PubMed ID: 3022531
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
    Suda T, Abe Y, Demura H, Demura R, Shizume K, Tamahashi N, Sasano N.
    J Clin Endocrinol Metab; 1979 Sep 29; 49(3):475-7. PubMed ID: 224076
    [Abstract] [Full Text] [Related]

  • 17. Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.
    Gibbs DM, Vale W.
    Endocrinology; 1982 Oct 29; 111(4):1418-20. PubMed ID: 6288364
    [Abstract] [Full Text] [Related]

  • 18. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states.
    Westphal M, Lüdecke DK.
    Mol Cell Endocrinol; 1984 Sep 29; 37(2):145-51. PubMed ID: 6092171
    [Abstract] [Full Text] [Related]

  • 19. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.
    Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C.
    Endocrinology; 1983 Sep 29; 113(3):1121-31. PubMed ID: 6307665
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.